1. Home
  2. KROS vs NFBK Comparison

KROS vs NFBK Comparison

Compare KROS & NFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • NFBK
  • Stock Information
  • Founded
  • KROS 2015
  • NFBK 1887
  • Country
  • KROS United States
  • NFBK United States
  • Employees
  • KROS N/A
  • NFBK N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • NFBK Major Banks
  • Sector
  • KROS Health Care
  • NFBK Finance
  • Exchange
  • KROS Nasdaq
  • NFBK Nasdaq
  • Market Cap
  • KROS 565.0M
  • NFBK 496.7M
  • IPO Year
  • KROS 2020
  • NFBK 2007
  • Fundamental
  • Price
  • KROS $15.91
  • NFBK $10.99
  • Analyst Decision
  • KROS Buy
  • NFBK Buy
  • Analyst Count
  • KROS 14
  • NFBK 2
  • Target Price
  • KROS $20.56
  • NFBK $13.00
  • AVG Volume (30 Days)
  • KROS 424.2K
  • NFBK 214.3K
  • Earning Date
  • KROS 11-05-2025
  • NFBK 10-27-2025
  • Dividend Yield
  • KROS N/A
  • NFBK 4.75%
  • EPS Growth
  • KROS N/A
  • NFBK 28.89
  • EPS
  • KROS 0.47
  • NFBK 0.86
  • Revenue
  • KROS $232,844,000.00
  • NFBK $133,079,000.00
  • Revenue This Year
  • KROS $6,657.47
  • NFBK $8.04
  • Revenue Next Year
  • KROS N/A
  • NFBK $23.35
  • P/E Ratio
  • KROS $34.14
  • NFBK $12.70
  • Revenue Growth
  • KROS 85820.30
  • NFBK 4.86
  • 52 Week Low
  • KROS $9.12
  • NFBK $9.40
  • 52 Week High
  • KROS $72.37
  • NFBK $14.39
  • Technical
  • Relative Strength Index (RSI)
  • KROS 54.08
  • NFBK 34.73
  • Support Level
  • KROS $15.50
  • NFBK $11.45
  • Resistance Level
  • KROS $16.44
  • NFBK $11.50
  • Average True Range (ATR)
  • KROS 0.57
  • NFBK 0.27
  • MACD
  • KROS -0.01
  • NFBK -0.11
  • Stochastic Oscillator
  • KROS 59.87
  • NFBK 11.98

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About NFBK Northfield Bancorp Inc. (Delaware)

Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.

Share on Social Networks: